Document is current
Any future updates will be listed below
-
Authors
Nezu, Tomoyuki
Ide, Tomomi
Fujino, Takeo https://orcid.org/0000-0002-2886-3479
Tohyama, Takeshi
Higuchi, Tae
Nagatomi, Yuta
Komman, Hitoshi
Toyosawa, Masayo
Nagata, Takuya
Ishikawa, Yusuke
Ikeda, Masataka
Hashimoto, Toru
Kinugawa, Shintaro
Tsutsui, Hiroyuki
Shiose, Akira
Abe, Kohtaro
-
Funding
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (20FC1051)
Japan Society for the Promotion of Science (22K08103)
Japan Society for the Promotion of Science (22K16141)
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 10 September 2025
First Online: 13 November 2025
Declarations
:
: Takeo Fujino is a member of endowment department supported by Nipro Corporation, Abbott Medical Japan, and Medtronic. Hiroyuki Tsutsui has received remunerations from Kowa, Teijin Pharma, Nippon Boehringer Ingelheim, Mitsubishi Tanabe Pharma, Pfizer Japan, Ono Pharmaceutical, Daiichi Sankyo, Novartis Pharma, Bayer Yakuhin, Otsuka Pharmaceutical, and AstraZeneca; has received manuscript fees from Nippon Rinsho; has received research funding from Mitsubishi Tanabe Pharma, Nippon Boehringer Ingelheim, IQVIA Services Japan, MEDINET, Medical Innovation Kyushu, Kowa, Daiichi Sankyo, Johnson & Johnson, and NEC Corporation; and has received scholarship funds or donations from Abbott Medical Japan, Otsuka Pharmaceutical, Boston Scientific Japan, Ono Pharmaceutical, Bayer Yakuhin, Nippon Boehringer Ingelheim, St. Mary’s Hospital, Teijin Pharma, Daiichi Sankyo, and Mitsubishi Tanabe Pharma. Other authors declare no conflict of interest.
